Physician

Thomas John Federici, MD

According to 2025 Medicare claims, Thomas Federici, MD (NPI: 1427055672) practices ophthalmology in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Albany, NY. This provider's primary affiliated billing organization is SHALOM KIEVAL MD PC (NPI: 1821316928) and primary practice location at 12110-2103.

Federici's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 900 traditional Medicare patients, billed 46,200 HCPCS/CPT codes, and received $2,847,285 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 357 prescription claims across 106 beneficiaries totaling $36,552 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 3 records totaling $123. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $14,859 to $36,552. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.2M2015 Medicare payment: $3,165,175 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,181,471 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,903,014 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,604,746 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,165,890 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,633,908 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,576,682 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,029,057 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,854,217 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,847,285 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201581312,317$3,165,175
201690012,326$3,181,471
201788511,264$2,903,014
201891610,243$2,604,746
201987312,111$3,165,890
202085310,238$2,633,908
202193110,798$2,576,682
202294815,468$3,029,057
202388632,792$2,854,217
202490046,200$2,847,285

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$21K$41K2015 Drug cost: $14,859 (USD; Tot_Drug_Cst)2016 Drug cost: $16,647 (USD; Tot_Drug_Cst)2017 Drug cost: $21,587 (USD; Tot_Drug_Cst)2018 Drug cost: $13,344 (USD; Tot_Drug_Cst)2019 Drug cost: $19,259 (USD; Tot_Drug_Cst)2020 Drug cost: $28,660 (USD; Tot_Drug_Cst)2021 Drug cost: $41,166 (USD; Tot_Drug_Cst)2022 Drug cost: $40,512 (USD; Tot_Drug_Cst)2023 Drug cost: $30,985 (USD; Tot_Drug_Cst)2024 Drug cost: $36,552 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201563152$14,859
201658161$16,647
201761180$21,587
201860149$13,344
201952148$19,259
202054192$28,660
202163240$41,166
202249224$40,512
202364231$30,985
2024106357$36,552

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1501,178$650
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more144144$118
67028Injection of drug into eye3771,730$95
92014Established patient complete exam of visual system656848$91
92134Imaging of retina8011,952$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium431,090$8,285
IlevroNepafenac13312$5,382
Prednisolone AcetatePrednisolone Acetate812,996$3,691
Brimonidine TartrateBrimonidine Tartrate15548$1,333
Atropine SulfateAtropine Sulfate441,735$1,160

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$123Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Thomas John Federici, MD?

Tedicare shows public-source Medicare data for Thomas John Federici, MD (NPI 1427055672), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas John Federici, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thomas John Federici, MD?

Thomas John Federici, MD is linked to SHALOM KIEVAL MD PC (billing NPI 1821316928) in the available physician profile data.

Does Thomas John Federici, MD have Open Payments data?

Thomas John Federici, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.